Erlotinib in Treating Patients With Breast Cancer That Can Be Removed by Surgery

NCT00633750 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Vanderbilt-Ingram Cancer Center

Collaborators